4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-045230
EVP, Research & CSO acquired 78,093 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2022-08-09 | Option exercise | +70,177 | $1.53 | $107,371 | 254,584 | D |
| Virgin Herbert EVP, Research & CSO | 2022-08-09 | Option exercise | +7,916 | $10.40 | $82,287 | 262,500 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2022-08-09 | Option exercise · Stock Option (Right to Buy) | −70,177 | 140,328 | D | ||
| Virgin Herbert EVP, Research & CSO | 2022-08-09 | Option exercise · Stock Option (Right to Buy) | −7,916 | 125,416 | D | ||
Loading xslF345X03/doc4.xml…